兰卫医学
(301060)
| 流通市值：37.28亿 | | | 总市值：41.45亿 |
| 流通股本：3.60亿 | | | 总股本：4.01亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 744,954,061.17 | 707,630,098.06 | 744,823,091.7 | 828,951,466.14 |
| 交易性金融资产 | - | - | 54,951,715.73 | - |
| 应收票据及应收账款 | 728,645,093.59 | 818,044,061.68 | 758,465,233.35 | 789,299,499.6 |
| 其中：应收票据 | 1,674,235.99 | 1,231,179.14 | 1,271,977.69 | 2,584,099.64 |
| 应收账款 | 726,970,857.6 | 816,812,882.54 | 757,193,255.66 | 786,715,399.96 |
| 应收款项融资 | 1,055,639.65 | 4,441,890.82 | 13,955,963.38 | 18,931,236.37 |
| 预付款项 | 4,870,297.73 | 3,883,493.2 | 10,423,796.74 | 4,757,068.96 |
| 其他应收款合计 | 8,039,292.1 | 7,810,547.36 | 14,304,164.31 | 14,537,235.68 |
| 存货 | 319,963,258.21 | 328,539,465.38 | 369,701,449.12 | 306,089,217.82 |
| 合同资产 | 461,440 | 496,850 | 462,646 | 397,666 |
| 其他流动资产 | 35,710,007.91 | 36,755,439.13 | 40,229,490.92 | 35,677,207.52 |
| 流动资产合计 | 1,843,699,090.36 | 1,907,601,845.63 | 2,007,317,551.25 | 1,998,640,598.09 |
| 非流动资产: | | | | |
| 长期股权投资 | 1,472,518.11 | 1,592,983.3 | 1,689,271.35 | 1,759,448.9 |
| 固定资产 | 434,849,507.23 | 433,443,511.28 | 441,222,630.87 | 451,114,120.38 |
| 在建工程 | 3,109,600 | 3,928,354.54 | 2,421,373.47 | 991,843.26 |
| 使用权资产 | 22,071,625.82 | 24,207,256.3 | 27,047,883.13 | 30,477,841.97 |
| 无形资产 | 21,168,724.88 | 22,257,861.81 | 23,267,836.46 | 24,453,883.34 |
| 商誉 | 7,664,887.29 | 7,664,887.29 | 7,664,887.29 | 7,664,887.29 |
| 长期待摊费用 | 21,169,441.57 | 23,132,609.88 | 26,579,967.89 | 30,040,684.88 |
| 递延所得税资产 | 73,225,865.25 | 73,993,967.52 | 75,265,516.23 | 73,823,620.88 |
| 其他非流动资产 | 2,327,188.84 | 8,304,693.88 | 3,772,697.97 | 4,367,497.71 |
| 非流动资产合计 | 587,059,358.99 | 598,526,125.8 | 608,932,064.66 | 624,693,828.61 |
| 资产总计 | 2,430,758,449.35 | 2,506,127,971.43 | 2,616,249,615.91 | 2,623,334,426.7 |
| 流动负债: | | | | |
| 短期借款 | 50,026,383.56 | 60,019,691.77 | 95,070,833.33 | 95,106,330.14 |
| 应付票据及应付账款 | 446,972,029.46 | 450,286,390.27 | 434,488,278.85 | 388,993,543.18 |
| 其中：应付票据 | 0 | - | - | - |
| 应付账款 | 446,972,029.46 | 450,286,390.27 | 434,488,278.85 | 388,993,543.18 |
| 合同负债 | 10,913,616.64 | 11,258,153.62 | 14,425,463.89 | 15,116,271.56 |
| 应付职工薪酬 | 24,044,212.55 | 28,377,920.12 | 25,762,971.5 | 37,799,678.56 |
| 应交税费 | 11,515,903.28 | 10,156,717.7 | 17,229,673.92 | 24,212,317.07 |
| 其他应付款合计 | 26,985,203.77 | 88,981,481.95 | 13,776,866.09 | 25,324,861.74 |
| 应付股利 | 13,320,000 | 79,920,000 | - | - |
| 一年内到期的非流动负债 | 27,207,737.18 | 27,683,584.83 | 27,824,439.6 | 27,217,490.25 |
| 其他流动负债 | 1,204,839.82 | 1,368,772.61 | 1,739,088.51 | 1,818,902.71 |
| 流动负债合计 | 598,869,926.26 | 678,132,712.87 | 630,317,615.69 | 615,589,395.21 |
| 非流动负债: | | | | |
| 长期借款 | 117,500,000 | 125,700,000 | 125,700,000 | 133,700,000 |
| 租赁负债 | 10,113,929.84 | 11,037,440.75 | 13,841,201.02 | 18,267,149.57 |
| 预计负债 | 26,340,249.76 | 25,820,249.76 | 25,020,662.23 | 25,020,662.23 |
| 递延收益 | 7,604,009.04 | 8,531,949.91 | 9,459,890.78 | 10,420,720.53 |
| 非流动负债合计 | 161,558,188.64 | 171,089,640.42 | 174,021,754.03 | 187,408,532.33 |
| 负债合计 | 760,428,114.9 | 849,222,353.29 | 804,339,369.72 | 802,997,927.54 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 400,517,000 | 400,517,000 | 400,517,000 | 400,517,000 |
| 资本公积 | 553,960,780.01 | 553,960,780.01 | 553,960,780.01 | 553,960,780.01 |
| 减:库存股 | 23,006,777.49 | 23,006,777.49 | 23,006,777.49 | 23,006,777.49 |
| 其他综合收益 | -653,308.3 | -653,308.3 | -653,308.3 | -653,308.3 |
| 盈余公积 | 86,525,659.79 | 86,525,659.79 | 86,525,659.79 | 86,525,659.79 |
| 未分配利润 | 560,413,145.97 | 555,297,714.17 | 632,704,207.49 | 640,785,068.28 |
| 归属于母公司股东权益合计 | 1,577,756,499.98 | 1,572,641,068.18 | 1,650,047,561.5 | 1,658,128,422.29 |
| 少数股东权益 | 92,573,834.47 | 84,264,549.96 | 161,862,684.69 | 162,208,076.87 |
| 股东权益合计 | 1,670,330,334.45 | 1,656,905,618.14 | 1,811,910,246.19 | 1,820,336,499.16 |
| 负债和股东权益合计 | 2,430,758,449.35 | 2,506,127,971.43 | 2,616,249,615.91 | 2,623,334,426.7 |
| 公告日期 | 2025-10-28 | 2025-08-26 | 2025-04-28 | 2025-04-28 |
| 审计意见(境内) | | | | 标准无保留意见 |